Publication: Clinical proteomics: A need to define the field and to begin to set adequate standards
Issued Date
2007-02-01
Resource Type
ISSN
18628346
Other identifier(s)
2-s2.0-34047209848
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Proteomics - Clinical Applications. Vol.1, No.2 (2007), 148-156
Suggested Citation
Harald Mischak, Rolf Apweiler, Rosamonde E. Banks, Mark Conaway, Joshua Coon, Anna Dominiczak, Jochen H.H. Ehrich, Danilo Fliser, Mark Girolami, Henning Hermjakob, Denis Hochstrasser, Joachim Jankowski, Bruce A. Julian, Walter Kolch, Ziad A. Massy, Christian Neusuess, Jan Novak, Karlheinz Peter, Kasper Rossing, Joost Schanstra, O. John Semmes, Dan Theodorescu, Visith Thongboonkerd, Eva M. Weissinger, Jennifer E. Van Eyk, Tadashi Yamamoto Clinical proteomics: A need to define the field and to begin to set adequate standards. Proteomics - Clinical Applications. Vol.1, No.2 (2007), 148-156. doi:10.1002/prca.200600771 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/24257
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Clinical proteomics: A need to define the field and to begin to set adequate standards
Author(s)
Harald Mischak
Rolf Apweiler
Rosamonde E. Banks
Mark Conaway
Joshua Coon
Anna Dominiczak
Jochen H.H. Ehrich
Danilo Fliser
Mark Girolami
Henning Hermjakob
Denis Hochstrasser
Joachim Jankowski
Bruce A. Julian
Walter Kolch
Ziad A. Massy
Christian Neusuess
Jan Novak
Karlheinz Peter
Kasper Rossing
Joost Schanstra
O. John Semmes
Dan Theodorescu
Visith Thongboonkerd
Eva M. Weissinger
Jennifer E. Van Eyk
Tadashi Yamamoto
Rolf Apweiler
Rosamonde E. Banks
Mark Conaway
Joshua Coon
Anna Dominiczak
Jochen H.H. Ehrich
Danilo Fliser
Mark Girolami
Henning Hermjakob
Denis Hochstrasser
Joachim Jankowski
Bruce A. Julian
Walter Kolch
Ziad A. Massy
Christian Neusuess
Jan Novak
Karlheinz Peter
Kasper Rossing
Joost Schanstra
O. John Semmes
Dan Theodorescu
Visith Thongboonkerd
Eva M. Weissinger
Jennifer E. Van Eyk
Tadashi Yamamoto
Other Contributor(s)
Mosaiques Diagnostics and Therapeutics AG
European Bioinformatics Institute
St James's University Hospital
University of Virginia
University of Wisconsin Madison
University of Glasgow
Medizinische Hochschule Hannover (MHH)
Charité – Universitätsmedizin Berlin
Universite de Geneve
University of Alabama at Birmingham
Beatson Institute for Cancer Research
Inserm
University of Aalen
Baker Heart and Diabetes Institute
Steno Diabetes Center
Eastern Virginia Medical School
Mahidol University
Johns Hopkins University
Niigata University School of Medicine
CHU Amiens Picardie
European Bioinformatics Institute
St James's University Hospital
University of Virginia
University of Wisconsin Madison
University of Glasgow
Medizinische Hochschule Hannover (MHH)
Charité – Universitätsmedizin Berlin
Universite de Geneve
University of Alabama at Birmingham
Beatson Institute for Cancer Research
Inserm
University of Aalen
Baker Heart and Diabetes Institute
Steno Diabetes Center
Eastern Virginia Medical School
Mahidol University
Johns Hopkins University
Niigata University School of Medicine
CHU Amiens Picardie
Abstract
The aim of this manuscript is to initiate a constructive discussion about the definition of clinical proteomics, study requirements, pitfalls and (potential) use. Furthermore, we hope to stimulate proposals for the optimal use of future opportunities and seek unification of the approaches in clinical proteomic studies. We have outlined our collective views about the basic principles that should be considered in clinical proteomic studies, including sample selection, choice of technology and appropriate quality control, and the need for collaborative interdisciplinary efforts involving clinicians and scientists. Furthermore, we propose guidelines for the critical aspects that should be included in published reports. Our hope is that, as a result of stimulating discussion, a consensus will be reached amongst the scientific community leading to guidelines for the studies, similar to those already published for mass spectrometric sequencing data. We contend that clinical proteomics is not just a collection of studies dealing with analysis of clinical samples. Rather, the essence of clinical proteomics should be to address clinically relevant questions and to improve the state-of-the-art, both in diagnosis and in therapy of diseases. © 2007 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.